Thurston, Springer, Miller, Herd & Titak, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $475 Million
- Q4 2024
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 8 shares of REGN stock, worth $5,490. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8
Previous 6
33.33%
Holding current value
$5,490
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding REGN
# of Institutions
1,496Shares Held
82.8MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.4 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.8 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.14 Billion0.64% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.36 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$2.95 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $73.6B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...